Analysis of Industry 4.0 and Transformative Trends in Pharma

Pharma 4.0 represents a disruptive force that is revolutionizing the pharmaceutical industry. It is presenting newer opportunities for innovation, and patient-centric care. The smart manufacturing driven by advanced technologies like Artificial Intelligence (AI), Robotics, Internet of Things (IoT), Big Data Analytics (BDA) seeks to integrate digital technologies and automation to create smart, connected manufacturing facilities. The given study examined the applications of AI, big data analytics, and IoT across drug development and marketing processes. The study has used qualitative analysis through NVivo 14 to analyze the secondary data collected from white papers, industry reports, and peer-reviewed research articles. The findings suggested that data integrity, process innovation, and technology integration are critical dimensions for effective Pharma 4.0 implementation. Furthermore, strategy, technology, operations, culture, and people play crucial roles in driving this change. This study provides insights for stakeholders who want to leverage these technologies for improved efficiency and effectiveness in the pharmaceutical sector.

Authors

Publication Details

Journal
Journal of Information Systems Engineering & Management
Published
2025-03-20
DOI
https://doi.org/10.52783/jisem.v10i3.7783
Primary Topic
Technology and Data Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of Industry 4.0 and Transformative Trends in Pharma

Mrunal Joshi
1 links
Journal of Information Systems Engineering & Management
Technology and Data Analysis
article

Analysis of Industry 4.0 and Transformative Trends in Pharma

Mrunal Joshi
article en

Abstract

Pharma 4.0 represents a disruptive force that is revolutionizing the pharmaceutical industry. It is presenting newer opportunities for innovation, and patient-centric care. The smart manufacturing driven by advanced technologies like Artificial Intelligence (AI), Robotics, Internet of Things (IoT), Big Data Analytics (BDA) seeks to integrate digital technologies and automation to create smart, connected manufacturing facilities. The given study examined the applications of AI, big data analytics, and IoT across drug development and marketing processes. The study has used qualitative analysis through NVivo 14 to analyze the secondary data collected from white papers, industry reports, and peer-reviewed research articles. The findings suggested that data integrity, process innovation, and technology integration are critical dimensions for effective Pharma 4.0 implementation. Furthermore, strategy, technology, operations, culture, and people play crucial roles in driving this change. This study provides insights for stakeholders who want to leverage these technologies for improved efficiency and effectiveness in the pharmaceutical sector.

Journal of Information Systems Engineering & ManagementVol. 10(3)
Openalex Percentile: Top 87%
Technology and Data Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Analysis of Industry 4.0 and Transformative Trends in Pharma — Mrunal Joshi · Journal of Information Systems Engineering & Management (2025) | TGRS Research Map | TGRS